Revvity/RVTY

$100.77

-0.08%
-
1D1W1MYTD1YMAX

About Revvity

Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.

Ticker

RVTY

Sector

Healthcare

Trading on

NYSE

Industry

Scientific & Technical Instr.

CEO

Prahlad Singh

Employees

11,500

Headquarters

Waltham, United States

Revvity Metrics

BasicAdvanced
$12.46B
Market cap
18.34
P/E ratio
$5.50
EPS
1.08
Beta
$0.28
Dividend rate
0.28%
Dividend yield
$12.46B
1.08427
$135.67
$79.50
891.53K
$0.28
2.069
1.774
40.364
49.533
19.44%
29.812
4.07%
1.3%
2.35%
1.45%
18.338
4.53
1.581
0.2%
0.28%
0.28%
-16.95%
-64.44%
-10.08%
-39.5%

What the Analysts think about Revvity

Analyst Ratings

Majority rating from 19 analysts.
Buy

Price Targets

Average projection from 16 analysts.
25.03% upside
High $185.00
Low $108.00
$100.77
Current price
$125.99
Average price target

Revvity Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.28% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$695.9M
3.76%
Net income
$78.5M
735.11%
Profit margin
11.28%
705.71%

Revvity Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.42%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.01
$1.21
$1.18
$1.25
-
Expected
$1.06
$1.19
$1.19
$1.16
$0.93
Surprise
-5.05%
2.09%
-1.07%
7.42%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Revvity stock?

Revvity (RVTY) has a market cap of $12.46B as of April 23, 2024.

What is the P/E ratio for Revvity stock?

The price to earnings (P/E) ratio for Revvity (RVTY) stock is 18.34 as of April 23, 2024.

Does Revvity stock pay dividends?

Yes, the Revvity (RVTY) stock pays dividends to shareholders. As of April 23, 2024, the dividend rate is $0.28 and the yield is 0.28%. Revvity has a payout ratio of 19.44% on a trailing twelve-month basis.

When is the next Revvity dividend payment date?

The next Revvity (RVTY) dividend payment is scheduled for May 10, 2024.

What is the beta indicator for Revvity?

Revvity (RVTY) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Revvity stock price target?

The target price for Revvity (RVTY) stock is $125.99, which is 25.03% above the current price of $100.77. This is an average based on projections from 16 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Revvity stock

Buy or sell Revvity stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing